Detection of Bone Metastases by ⁶⁸Ga-DOTA-SSAs and ¹⁸F-FDG PET/CT: A Two-Center Head-to-Head Study of Gastroenteropancreatic Neuroendocrine Neoplasms

Table 2

Comparison of the detection SUV value of ¹⁸F-FDG PET/CT and ⁶⁸Ga-DOTA-SSAs PET/CT imaging.

Part	Liver metastases					Bone metastases
	N	Type	^18F-FDG	^68Ga-DOTA-SSAs	Wilcoxon P	N	Type	^18F-FDG	^68Ga-DOTA-SSAs	Wilcoxon P
Total	69	SUVT/B	2.29 ± 1.48	4.92 ± 4.50	≤0.001	74	SUVT/B	3.03 ± 2.64	25.70 ± 24.26	≤0.001
		Amount	10.67 ± 23.05	21.53 ± 31.41	0.010		Amount	9.81 ± 22.89	25.91 ± 36.87	≤0.001
G1 + G2	48	SUVT/B	1.70 ± 0.78	6.11 ± 4.83	≤0.001	50	SUVT/B	2.04 ± 1.33	30.29 ± 25.90	≤0.001
		Amount	5.44 ± 14.50	22.77 ± 30.53	≤0.001		Amount	7.36 ± 20.24	25.62 ± 36.39	≤0.001
G3	11	SUVT/B	3.45 ± 2.17	2.31 ± 2.34	0.110	12	SUVT/B	4.32 ± 2.95	16.88 ± 15.75	0.049
		Amount	17.00 ± 28.79	16.64 ± 29.22	0.722		Amount	13.75 ± 28.50	24.50 ± 37.10	0.026
NEC	10	SUVT/B	3.98 ± 1.21	2.26 ± 1.77	0.280	12	SUVT/B	5.50 ± 3.95	12.76 ± 16.39	0.272
		Amount	29.90 ± 37.90	22.70 ± 40.92	0.025		Amount	15.00 ± 28.23	22.33 ± 36.81	0.531